WO1994005261A1 - Anhydrous topical compositions which dry rapidly on contact - Google Patents

Anhydrous topical compositions which dry rapidly on contact Download PDF

Info

Publication number
WO1994005261A1
WO1994005261A1 PCT/US1992/007578 US9207578W WO9405261A1 WO 1994005261 A1 WO1994005261 A1 WO 1994005261A1 US 9207578 W US9207578 W US 9207578W WO 9405261 A1 WO9405261 A1 WO 9405261A1
Authority
WO
WIPO (PCT)
Prior art keywords
anhydrous
weight
composition
composition according
microspherical particles
Prior art date
Application number
PCT/US1992/007578
Other languages
French (fr)
Inventor
Leonard Mackles
Leonard Chavkin
Original Assignee
Leonard Mackles
Leonard Chavkin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/684,246 priority Critical patent/US5178881A/en
Priority claimed from US07/684,246 external-priority patent/US5178881A/en
Priority to US07/933,788 priority patent/US5294447A/en
Application filed by Leonard Mackles, Leonard Chavkin filed Critical Leonard Mackles
Priority to CA002123118A priority patent/CA2123118C/en
Priority to PCT/US1992/007578 priority patent/WO1994005261A1/en
Priority claimed from CA002123118A external-priority patent/CA2123118C/en
Publication of WO1994005261A1 publication Critical patent/WO1994005261A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/025Explicitly spheroidal or spherical shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • A61K2800/31Anhydrous
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/65Characterized by the composition of the particulate/core
    • A61K2800/654The particulate/core comprising macromolecular material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Definitions

  • This invention concerns anhydrous compositions for topical application which dry quickly after application, have substantially no greasy or oily feel and have good retention even when the skin is moistened.
  • Anhydrous liquids or semi-solids were the original topical ointment and lotion vehicles.
  • Mineral oil and petrolatum are examples, as are the animal and vegetable fats and oils, of the bases used as dermatological vehicles or cosmetic carriers.
  • Pharmaceutical formularies include ointments, creams and lotions, containing examples of anhydrous dermatological vehicles for topical application to the skin.
  • Newer washable systems are more easily removed so their action i fleeting.
  • the emulsifier in these systems used are sometimes irritating to the skin
  • the protective, emollient or moisturizing effect of the washable system is very significantly less than the anhydrous systems.
  • S ⁇ Bsr ⁇ r - Emulsions are inherently unstable systems that separate in time.
  • Moisturizing and skin protection properties are not diminished as in emulsion systems. Preservation problems, even in the absence of preservatives, are absent.
  • the anhydrous compositions which have the above desirable characteristics of both anhydrous and washable compositions comprise from 10 to 80% anhydrous base and 5 to 50% polyolefin microspherical particles of average diameter less than 25 microns.
  • the amount of polyolefin microspherical particles in the composition is from 30 to 130% by weight of the base.
  • These anhydrous compositions may be in lotion, ointment, solid or aerosol form.
  • the anhydrous compositions may contain from 1 to 50% of an active ingredient. Suitable active ingredients for these compositions are antiperspirant, analgesic, sunscreen and insect repellent compounds.
  • the anhydrous compositions of the invention are made by conventional mixing techniques.
  • Anhydrous bases for use in the invention include animal, vegetable and mineral fats or oils or synthetic anhydrous substances, all of which have a melting point of below 50°C.
  • Suitable animal fats include lanolin, lard, fish oils and fish liver oils.
  • Suitable vegetable oils include cotton seed, corn, soybean, canola and castor oil as well as, coconut oil and cocoa butter. Also suitable are mineral oils and petrolatums.
  • Suitable synthetic substances include isopropyl fatty acid esters such as palmitate and myristate; glycerol monolaurate or monooleate; polyglyceryl fatty acid esters; medium chain triglycerides (i.e., C4 to C14); acetylated monoglycerides; propylene glycol; polypropylene oxide polymers and their fatty acid esters; glycerin; polyethylene oxide polymers and their fatty acid esters; isostearyl alcohol, silicone oils and esters such as cyclomethicones; e.g., octamethylcyclotetrasiloxane.
  • a l t h o u g h t h e s u i t a b l e c y c l o m e t h i c o n e s s u c h a octamethylcyclotetrasiloxane and decamethyl-cyclopentasiloxane are volatile silicones they are not as volatile as ethanol. Therefore, cyclomethicones do no feel cold on the skin when applied thereto and are not perceived to be wet.
  • anhydrous "absorbable" oils ar suitable as bases in the invention. These include, ethyl phthalate, butyl phthalate polyoxypropylene 14 butyl ether, polyoxypropylene 15 stearyl ether and othe liquid esters and ethers. Although all of these oily materials feel warm and dr
  • one or more of these base materials may be combined in the anhydrous compositions in order to yield a liquid semisolid or solid composition at room temperature. Additionally, different combinations of base substances may be made to produce a liquid composition having a desirable viscosity.
  • the polyolefin microspherical particles suitable for use in the anhydrous compositions are well known.
  • the preferred particles for use in the composition are those having average diameter of less than 25 microns.
  • One such material is a microfine polyolefin powder produced by U.S.I. Chemicals: "Microthene” is a polyethylene with regular spherical uniform particles of average diameter of less than 20 microns. These particles have a density of 0.915-0.960 grams per cubic centimeter, a melt index of 5-55 (g/10 min.) and a softening point between 75-128°C.
  • Most preferred of the polyolefin powders is Microthene FN 510.
  • polyolefin microspherical particles form a low density material with small particle size, the particles do not readily settle in liquid systems. Therefore, problems of settling and packing are eliminated.
  • the polyolefin microspherical particles are suitably incorporated in the anhydrous compositions at from 5 to 50% by weight of the composition and in an amount which is from 30 to 130% by weight of the base material present in the composition.
  • the composition may include from 30 to 40% by weight of the polyolefin microspherical particles.
  • antiperspirant compounds include aluminum chloride, aluminum chlorohydrate, aluminum chloro- hydrate-propyleneglycol complex, aluminum zirconiumtetrachlorohydrate-glycine and aluminum pentachlorohydrate. Many of these antiperspirant compounds are usually found in the form of fine powders. As such, the antiperspirant materials may be suspended in the anhydrous system where they remain relatively inert until they come in contact with moisture from the skin.
  • the anhydrous compositions may suitably include antiperspirant compound at a level of 5 to 50% by weight of the composition, preferably 10 to 30% by weight of the composition.
  • insect repellent e.g., N,N-diethyl toluamide DEET
  • sunscreen octyl dimethyl
  • PABA PABA
  • analgesic compounds e.g., methyl salicylate.
  • the amounts of these active ingredients may also be 1 to 50% by weight of the composition o alternatively, 20 to 30% by weight of the composition.
  • Optional ingredients for including in the anhydrous compositions include waxes, fragrances, talcs, germicides, color and suspending agents such as fume silica or treated bentonites.
  • the anhydrous compositions of the invention may take several forms liquid, ointment, solid stick or aerosol. In each of these forms the anhydrou composition, when applied, achieves a smooth dry application with no greasy o oily feel.
  • anhydrous composition which is a lotion, the bas
  • - B ⁇ T.T ' includes mineral oil and lanolin accompanied by the Microthene FN510.
  • the base may be triglyceride or isopropyl myristate.
  • the base may be white petrolatum and where a cream is desired may be mineral oil.
  • Aerosol embodiments of the anhydrous composition may be made by conventional methods thus, an initial concentrate is made including anhydrous base with polyolefin microspherical particles optionally with active ingredient or other elements. The concentrate is then added to a propellent (e. g. isobutane) and submitted for aerosol filling.
  • a propellent e. g. isobutane
  • the anhydrous base and polyolefin microspherical particles should be stirred together and subjected to high speed mixing to achieve uniform dispersion.
  • the base should initially be heated sufficient to render it easily mixable; for example, where the base is decamethyl cyclopentasiloxane and stearyl alcohol, the base material may suitable be heated to 70°C prior to addition of the polyolefin microspherical particles. This heating renders the mixing step easier and effects suitable dispersion of the microspherical particles more quickly and easily.
  • the concentrate includes the anhydrous base, as well as, polyolefin microspherical particles and other active or optional ingredients. As with lotions, ointments and sticks this concentrate is made by
  • the homogenized concentrate is then combined with sufficient propellant for example, isobutane under pressure and this "aerosol fill" is then subjected to filling in pressurized containers.
  • sufficient propellant for example, isobutane under pressure and this "aerosol fill" is then subjected to filling in pressurized containers.
  • An anhydrous hand and skin lotion composition comprising 50% mineral oil (USP 200/210 SSU) 5% lanolin (anhydrous) and 45% Microthene FN510.
  • the lotion is made by initially heating the mineral oil and lanolin together to 60°C. Upon reaching this temperature the FN510 is stirred in followed by cooling to room temperature.
  • the resultant hand and skin lotion rubs in dry almost instantly to give a smooth, silky feel to the skin.
  • An anhydrous after bath lotion composition comprising 55% isopropyl myristate, 44% Microthene FF510 and 1 % Cabosil M-5 (fumed silica) . All ingredients are mixed without heating under high speed stirring to achieve uniform dispersion. The resultant after bath lotion rubs into the skin to give a smooth soft feel without oily or greasiness.
  • This petrolatum ointment rubs into the skin almost immediately leaving a dry and powdery feeling on the surface in contrast to untreated petrolatum which leaves a greasy and messy feeling.
  • a topical analgesic ointment is made including 19% methyl salicylate, 15% menthol USP, 25% white petrolatum USP, 40% Microthene FN510 and 1 % Cabosil M-5 (fumed silica).
  • the methyl salicylate, menthol and petrolatum are combined in mixing vessel and heated together to 60°C.
  • the microspheres are then added to the liquified mixture and stirred at high speed to achieve uniform dispersion.
  • the fumed silica is added; the batch is then cooled to room temperature and removed into a storage vessel.
  • An anhydrous liquid roll-on antiperspirant composition is made from the following:
  • Microthene FN510 33.00 Polyoxypropylene 14 butyl ether 4.00
  • the cyclomethicone and the polyoxypropylene 14 butyl ether are mixed with high speed stirring.
  • the ACH is then stirred in followed by the FN510.
  • ITUTE SHEET batch is mixed until uniform. The batch is homogenized for uniformity and then packaged in roll-on containers.
  • antiperspirant active chemicals may be substituted for the ACH without any noticeable difference.
  • An anhydrous antiperspirant cream composition is made from the following:
  • Cyclomethicone is mixed in a mixing vessel with the ACH and the polyoxypropylene 14 butyl ether. When this mixture is uniform the microspheres
  • FN510 are added with high speed mixing until the mixture is smooth and uniform. At this point, the fumed silicon dioxide is added to the mixing vessel and high speed mixing until a uniform paste is formed.
  • the resulting antiperspirant cream ointment delivers a product which feels dry upon application.
  • Other antiperspirant actives may be substituted for ACH without noticeable difference.
  • SHEET EXAMPLE 7 An anhydrous antiperspirant stick composition is made from the following:
  • Ingredients 1 , 3 and 5 are heated in a mixing vessel to 70°C until all are melted. At this point, the three ingredients are mixed until uniform. ACH is then stirred into the mixture with high speed mixing until uniform afterward, the microsphere FN510 are stirred into the mixture, high speed mixing again occurs to achieve uniform dispersion. The resulting uniform mixture is cooled to 55- 60°C, the product is then poured into stick mold containers and cooled.
  • anhydrous antiperspirant stick compositions rub off on the skin as a powder rather than as a gelled liquid.
  • Other active antiperspirant chemical may used in lieu of ACH without any noticeable difference.
  • An anhydrous aerosol concentrate composition is made from the following:
  • IPM Isopropyl myristate
  • TITUTE SHEET Isopropyl myristate and the Bentone 38 are added in a mixing vessel to the cyclomethicone.
  • the three ingredients are mixed under a high speed stirring, after which time, the Bentone has expanded and the mixture is uniform.
  • the ACH is stirred into the mixture at high speed, subsequent to which the microspheres FN510 are blended in at high speed mixing.
  • the mixture is then homogenized.
  • This concentrate is made into an aerosol fill by adding concentrate to propellent isobutane propellant in a ratio of 30% concentrate to 70% isobutane.
  • the aerosol fill is then submitted for filling in pressurized containers.
  • the resulting aerosol antiperspirant delivers a dry powder upon application.
  • EXAMPLE 9 An insect repellent lotion is made from the following:
  • the DEET and ethyl alcohol are mixed in a mixing vessel until uniform after which, the FN510 microspheres are added with high speed mixing to achieve uniform dispersion.
  • the DEET is both a carrier and an active constituent.
  • the resulting insect repellent lotion dries almost instantaneously when rubbed into the skin.
  • a sun protectant lotion is made from the following:
  • the octyl dimethyl PABA and benzophenone-3 are heated together to 50°C in a mixing vessel, at this point the mixture is clear.
  • the mineral oil is then stirred into the mixture at medium speed stirring.
  • the FN510 microspheres are added with high speed stirring to achieve uniform dispersion.
  • the batch is cooled to room temperature and removed to a storage vessel.
  • the resulting sunscreen lotion rubs into the skin immediately without stickiness, yet is completely dry to the touch and water resistant.
  • the skin bleaching lotion rubs into the skin without any sign of greasiness
  • the glycerin lotion rubs into the skin without any feeling of stickiness and dries almost instantly to give a smooth feel.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

A substantially anhydrous composition suitable for topical application which contains 10-80 % by weight of an anhydrous base which is liquid or semi-solid at room temperature; and 5-50 % by weight of polyolefin microspherical particles having an average diameter of less than 25 microns, the amount of microspherical particles constituting at least 30 % by weight of the anhydrous base.

Description

ANHYDROUS TOPICAL COMPOSITIONS WHICH DRY RAPIDLY ON CONTACT
FIELD OF THE INVENTION This invention concerns anhydrous compositions for topical application which dry quickly after application, have substantially no greasy or oily feel and have good retention even when the skin is moistened.
BACKGROUND OF THE INVENTION There are many products intended for application to the skin for therapeutic or cosmetic purposes that are best formulated as anhydrous systems. Anhydrous liquids or semi-solids were the original topical ointment and lotion vehicles. Mineral oil and petrolatum are examples, as are the animal and vegetable fats and oils, of the bases used as dermatological vehicles or cosmetic carriers. Pharmaceutical formularies include ointments, creams and lotions, containing examples of anhydrous dermatological vehicles for topical application to the skin.
Although these anhydrous topical bases were excellent delivery systems for medications and were proven to be the best skin protective and moisturizing agents, their use is limited by the fact that consumers reject them on the basi of their greasy feel. This essential negative has limited their application t products for serious therapeutic and cosmetic uses, where their greasiness i tolerated.
There have been several attempts to make dermatological vehicles mor aesthetically acceptable. In one such attempt clays, starches, polysaccharides o cellulosics have been used to replace the oils in anhydrous systems in order to dr them out. These substitutions have generally been without success. While th substitute materials can be used in small amounts they are usually not successfu unless used in large amounts, where these particular materials cause the product to become pasty and sticky and to cause agglomeration of settling materials or clogging in aerosols.
In a further effort to improve dermatological vehicles, water soluble and water dispersible (washable) systems were developed. The majority of these were oil-in-water emulsion systems in which the oil was dispersed in at least 50% water to form a lotion or a cream. These creams spread easily on the skin, were rubbed in, or were absorbed rapidly with reduced greasiness or stickiness and are much more cosmetically elegant and acceptable to consumers.
Although these systems have thus been considered superior to anhydrou topical bases, they suffer from some negatives as compared to the origina anhydrous systems.
Newer washable systems are more easily removed so their action i fleeting.
They are perceived as wet and cold feeling during application and requir time for rub-in or absorption to feel dry.
The emulsifier in these systems used are sometimes irritating to the skin
The protective, emollient or moisturizing effect of the washable system is very significantly less than the anhydrous systems.
Water sometimes results in active ingredient instability; as with antibiotics
Water presents microbiological problems requiring the use of preservative
SϋBsr<r - Emulsions are inherently unstable systems that separate in time.
SUMMARY OF THE INVENTION We have discovered a novel way to achieve the elegance of a cosmetic compositions cream without the use of water or emulsion systems. We have found that the incorporation of polyolefin microspherical particles (PMP) into anhydrous compositions will render these compositions cosmetically elegant. Greasiness or stickiness is eliminated: absorption to a dry feel is rapid, and a smooth soft feel on the skin is achieved almost instantly.
None of the positive attributes of the oily bases is sacrificed. Since water and emulsifiers are not required, irritation is eliminated, instability of active ingredients is avoided, wetness and slow drying are eliminated.
Moisturizing and skin protection properties are not diminished as in emulsion systems. Preservation problems, even in the absence of preservatives, are absent.
In the application of our invention we have found it possible to modify the application properties of a variety of commonly used anhydrous liquid or semisolid (m.p. below 50°C) topical agents to achieve a smooth, dry application by the inclusion of at least 30% PMP by weight, of the oils present.
The anhydrous compositions which have the above desirable characteristics of both anhydrous and washable compositions comprise from 10 to 80% anhydrous base and 5 to 50% polyolefin microspherical particles of average diameter less than 25 microns. The amount of polyolefin microspherical particles in the composition is from 30 to 130% by weight of the base. These anhydrous compositions may be in lotion, ointment, solid or aerosol form. In addition to the base and microspherical particles, the anhydrous compositions may contain from 1 to 50% of an active ingredient. Suitable active ingredients for these compositions are antiperspirant, analgesic, sunscreen and insect repellent compounds. The anhydrous compositions of the invention are made by conventional mixing techniques.
DETAILED DESCRIPTION OF THE INVENTION Anhydrous bases for use in the invention include animal, vegetable and mineral fats or oils or synthetic anhydrous substances, all of which have a melting point of below 50°C. Suitable animal fats include lanolin, lard, fish oils and fish liver oils. Suitable vegetable oils include cotton seed, corn, soybean, canola and castor oil as well as, coconut oil and cocoa butter. Also suitable are mineral oils and petrolatums. Suitable synthetic substances include isopropyl fatty acid esters such as palmitate and myristate; glycerol monolaurate or monooleate; polyglyceryl fatty acid esters; medium chain triglycerides (i.e., C4 to C14); acetylated monoglycerides; propylene glycol; polypropylene oxide polymers and their fatty acid esters; glycerin; polyethylene oxide polymers and their fatty acid esters; isostearyl alcohol, silicone oils and esters such as cyclomethicones; e.g., octamethylcyclotetrasiloxane.
A l t h o u g h t h e s u i t a b l e c y c l o m e t h i c o n e s s u c h a octamethylcyclotetrasiloxane and decamethyl-cyclopentasiloxane are volatile silicones they are not as volatile as ethanol. Therefore, cyclomethicones do no feel cold on the skin when applied thereto and are not perceived to be wet.
In addition to these volatile silicones, other anhydrous "absorbable" oils ar suitable as bases in the invention. These include, ethyl phthalate, butyl phthalate polyoxypropylene 14 butyl ether, polyoxypropylene 15 stearyl ether and othe liquid esters and ethers. Although all of these oily materials feel warm and dr
SUBSTITUTE SHEET upon application, they are perceptibly greasy and oily unless combined in the composition of the invention.
It is understood that one or more of these base materials may be combined in the anhydrous compositions in order to yield a liquid semisolid or solid composition at room temperature. Additionally, different combinations of base substances may be made to produce a liquid composition having a desirable viscosity.
The polyolefin microspherical particles suitable for use in the anhydrous compositions are well known. Among the preferred particles for use in the composition are those having average diameter of less than 25 microns. One such material is a microfine polyolefin powder produced by U.S.I. Chemicals: "Microthene" is a polyethylene with regular spherical uniform particles of average diameter of less than 20 microns. These particles have a density of 0.915-0.960 grams per cubic centimeter, a melt index of 5-55 (g/10 min.) and a softening point between 75-128°C. Most preferred of the polyolefin powders is Microthene FN 510.
Because polyolefin microspherical particles form a low density material with small particle size, the particles do not readily settle in liquid systems. Therefore, problems of settling and packing are eliminated.
The polyolefin microspherical particles are suitably incorporated in the anhydrous compositions at from 5 to 50% by weight of the composition and in an amount which is from 30 to 130% by weight of the base material present in the composition. Preferably, the composition may include from 30 to 40% by weight of the polyolefin microspherical particles.
SUB Among the active ingredients suitable for inclusion in the anhydrous compositions are antiperspirant compounds. Suitable such antiperspirant compounds include aluminum chloride, aluminum chlorohydrate, aluminum chloro- hydrate-propyleneglycol complex, aluminum zirconiumtetrachlorohydrate-glycine and aluminum pentachlorohydrate. Many of these antiperspirant compounds are usually found in the form of fine powders. As such, the antiperspirant materials may be suspended in the anhydrous system where they remain relatively inert until they come in contact with moisture from the skin.
The anhydrous compositions may suitably include antiperspirant compound at a level of 5 to 50% by weight of the composition, preferably 10 to 30% by weight of the composition.
Other suitable active ingredients for the anhydrous compositions include insect repellent (e.g., N,N-diethyl toluamide DEET)); sunscreen (octyl dimethyl
PABA); and analgesic compounds (e.g., methyl salicylate). The amounts of these active ingredients may also be 1 to 50% by weight of the composition o alternatively, 20 to 30% by weight of the composition.
Optional ingredients for including in the anhydrous compositions includ waxes, fragrances, talcs, germicides, color and suspending agents such as fume silica or treated bentonites.
The anhydrous compositions of the invention may take several forms liquid, ointment, solid stick or aerosol. In each of these forms the anhydrou composition, when applied, achieves a smooth dry application with no greasy o oily feel.
One embodiment of the anhydrous composition which is a lotion, the bas
- BώT.T' includes mineral oil and lanolin accompanied by the Microthene FN510. Alternatively, the base may be triglyceride or isopropyl myristate.
Where the composition is an ointment embodiment the base may be white petrolatum and where a cream is desired may be mineral oil.
Aerosol embodiments of the anhydrous composition may be made by conventional methods thus, an initial concentrate is made including anhydrous base with polyolefin microspherical particles optionally with active ingredient or other elements. The concentrate is then added to a propellent (e. g. isobutane) and submitted for aerosol filling.
To make the lotion and ointment forms of the anhydrous composition the anhydrous base and polyolefin microspherical particles should be stirred together and subjected to high speed mixing to achieve uniform dispersion. When base materials of melting point above room temperature are being used the base should initially be heated sufficient to render it easily mixable; for example, where the base is decamethyl cyclopentasiloxane and stearyl alcohol, the base material may suitable be heated to 70°C prior to addition of the polyolefin microspherical particles. This heating renders the mixing step easier and effects suitable dispersion of the microspherical particles more quickly and easily.
Where additional ingredients are included in the composition they should be added step wise with mixing following the addition of each ingredient.
In order to make aerosol forms of the anhydrous compositions, a concentrate should first be made. The concentrate includes the anhydrous base, as well as, polyolefin microspherical particles and other active or optional ingredients. As with lotions, ointments and sticks this concentrate is made by
UTE SHEET mixing the ingredients step wise into the anhydrous base (liquified by heating if desirable). The mixing of these ingredients into the concentrate is again by high speed mixing to achieve uniform dispersion. Once the concentrate is formed it should be homogenized.
The homogenized concentrate is then combined with sufficient propellant for example, isobutane under pressure and this "aerosol fill" is then subjected to filling in pressurized containers.
ITUTE SHEET For a further understanding of the invention, reference is made to the following examples.
Unless otherwise noted, all percentages in this specification are percentages by weight of the composition.
EXAMPLE 1
An anhydrous hand and skin lotion composition is made comprising 50% mineral oil (USP 200/210 SSU) 5% lanolin (anhydrous) and 45% Microthene FN510. The lotion is made by initially heating the mineral oil and lanolin together to 60°C. Upon reaching this temperature the FN510 is stirred in followed by cooling to room temperature.
The resultant hand and skin lotion rubs in dry almost instantly to give a smooth, silky feel to the skin.
EXAMPLE 2
An anhydrous after bath lotion composition is made comprising 55% isopropyl myristate, 44% Microthene FF510 and 1 % Cabosil M-5 (fumed silica) . All ingredients are mixed without heating under high speed stirring to achieve uniform dispersion. The resultant after bath lotion rubs into the skin to give a smooth soft feel without oily or greasiness.
EXAMPLE 3 An anhydrous petrolatum ointment is made including 66.7% petrolatum
USP, White and 33.3 Microthene FN510. Initially the petrolatum is heated to 50°C until it is melted, the FN510 microspheres are then stirred in and the combination is subjected to high speed to achieve uniform dispersion. Th mixture is then cooled to 55°C and poured out of the mixing vessel into storag vessels.
This petrolatum ointment rubs into the skin almost immediately leaving a dry and powdery feeling on the surface in contrast to untreated petrolatum which leaves a greasy and messy feeling.
EXAMPLE 4 A topical analgesic ointment is made including 19% methyl salicylate, 15% menthol USP, 25% white petrolatum USP, 40% Microthene FN510 and 1 % Cabosil M-5 (fumed silica). In making this ointment, the methyl salicylate, menthol and petrolatum are combined in mixing vessel and heated together to 60°C. The microspheres are then added to the liquified mixture and stirred at high speed to achieve uniform dispersion. Afterward the fumed silica is added; the batch is then cooled to room temperature and removed into a storage vessel.
The resultant topical analgesic rubbed into the skin leaving no greasy feel thereon.
EXAMPLE 5 An anhydrous liquid roll-on antiperspirant composition is made from the following:
%
1. Decamethyl cyclopentasiloxane (Pentamer) 38.00
2. Microthene FN510 33.00 3. Polyoxypropylene 14 butyl ether 4.00
4. Aluminum chlorohydrate, ultra fine (ACH) 25.00
The cyclomethicone and the polyoxypropylene 14 butyl ether are mixed with high speed stirring. The ACH is then stirred in followed by the FN510. The
ITUTE SHEET batch is mixed until uniform. The batch is homogenized for uniformity and then packaged in roll-on containers.
Other antiperspirant active chemicals may be substituted for the ACH without any noticeable difference.
EXAMPLE 6 An anhydrous antiperspirant cream composition is made from the following:
%
1. Decamethyl cyclopentasiloxane (Pentamer) 39.00
2. Microthene FN510 29.00
3. Polyoxypropylene 14 butyl ether 4.00
4. Aluminum chlorohydrate (ACH) 25.00 5. Cabosil M-5 (Fumed Silicon Dioxide) 3.00
Cyclomethicone is mixed in a mixing vessel with the ACH and the polyoxypropylene 14 butyl ether. When this mixture is uniform the microspheres
FN510 are added with high speed mixing until the mixture is smooth and uniform. At this point, the fumed silicon dioxide is added to the mixing vessel and high speed mixing until a uniform paste is formed.
The resulting antiperspirant cream ointment delivers a product which feels dry upon application. Other antiperspirant actives may be substituted for ACH without noticeable difference.
SHEET EXAMPLE 7 An anhydrous antiperspirant stick composition is made from the following:
%
1 . Decamethyl cyclopentasiloxane (Pentamer) 26.00
2. Microthene FN510 35.00
3. Polyoxypropylene 15 stearyl ether 4.00
4. Aluminum chlorohydrate, ultra fine (ACH) 25.00
5. Stearyl alcohol 10.00
Ingredients 1 , 3 and 5 are heated in a mixing vessel to 70°C until all are melted. At this point, the three ingredients are mixed until uniform. ACH is then stirred into the mixture with high speed mixing until uniform afterward, the microsphere FN510 are stirred into the mixture, high speed mixing again occurs to achieve uniform dispersion. The resulting uniform mixture is cooled to 55- 60°C, the product is then poured into stick mold containers and cooled.
The resultant anhydrous antiperspirant stick compositions rub off on the skin as a powder rather than as a gelled liquid. Other active antiperspirant chemical may used in lieu of ACH without any noticeable difference.
EXAMPLE 8 An anhydrous aerosol concentrate composition is made from the following:
% 1 . Decamethyl cyclopentasiloxane (Pentamer) 31 .67
2. Microthene FN510 23.33
3. Aluminum chlorohydrate, standard powder (ACH) 36.67
4. Bentone 38, (Hectorite clay) 0.83
5. Isopropyl myristate (IPM) 7.50
TITUTE SHEET Isopropyl myristate and the Bentone 38 are added in a mixing vessel to the cyclomethicone. The three ingredients are mixed under a high speed stirring, after which time, the Bentone has expanded and the mixture is uniform. Then the ACH is stirred into the mixture at high speed, subsequent to which the microspheres FN510 are blended in at high speed mixing. The mixture is then homogenized. This concentrate is made into an aerosol fill by adding concentrate to propellent isobutane propellant in a ratio of 30% concentrate to 70% isobutane. The aerosol fill is then submitted for filling in pressurized containers.
The resulting aerosol antiperspirant delivers a dry powder upon application.
EXAMPLE 9 An insect repellent lotion is made from the following:
%
1 . N,N-diethyl toluamide (DEET) 40.00
2. SDA 40, ethyl alcohol 15.00
3. Microthene FN510 45.00
The DEET and ethyl alcohol are mixed in a mixing vessel until uniform after which, the FN510 microspheres are added with high speed mixing to achieve uniform dispersion. The DEET is both a carrier and an active constituent. The resulting insect repellent lotion dries almost instantaneously when rubbed into the skin.
SUBSTITUTE SH E¬E EXAMPLE 10 A sun protectant lotion is made from the following:
%
1 . Mineral Oil, USP 200/210 SSU 45.00 2. Octyl dimethyl PABA 8.00
3. Benzophenone-3 3.00
4. Microthene FN510 44.00
The octyl dimethyl PABA and benzophenone-3 are heated together to 50°C in a mixing vessel, at this point the mixture is clear. The mineral oil is then stirred into the mixture at medium speed stirring. Then the FN510 microspheres are added with high speed stirring to achieve uniform dispersion. The batch is cooled to room temperature and removed to a storage vessel. The resulting sunscreen lotion rubs into the skin immediately without stickiness, yet is completely dry to the touch and water resistant.
EXAMPLE 1 1 Skin Bleaching Lotion
% 1 . Hydroquinone USP 2.00
2. Caprylic triglyceride (med. chain triglyceride) 53.00
3. Microthene FN 510 45.00
100.00%
Heat the hydroquinone and medium chain triglyceride to 70°. Cool to 50° and stir in the FN 510 with high speed mixing.
The skin bleaching lotion rubs into the skin without any sign of greasiness
ITUTE SHEET EXAMPLE 12
Glycerin Hand Lotion
%
1 . Glycerin 48.00 2. SD 40, ethyl alcohol 17.00
3. Microthene FN510 35.00
100.00%
Mix the glycerin and ethyl alcohol until uniform. Mix in the Microthene FN510 with high speed, stirring until a uniform dispersion is achieved.
The glycerin lotion rubs into the skin without any feeling of stickiness and dries almost instantly to give a smooth feel.
T

Claims

We Claim:
1 . A substantially anhydrous composition suitable for topical application comprising: a) 10-80% by weight of an anhydrous base which is liquid or semi-solid at room temperature; and b) 5-50% by weight of polyolefin microspherical particles having an average diameter of less than 25 microns, where the amount of microspherical particles constitutes at least 30% by weight of the an hydrous base.
2. A composition according to Claim 1 in the form of a lotion, wherein the base is mineral oil or glycerin.
3. An composition according to Claim 1 in the form of an ointment, wherein the base is petrolatum.
4. An composition according to Claim 1 in the form of an aerosol concentrate, comprising 10-80% deamethyl cyclopentasiloxane (pentamer) 5-
50% polyolefin microspherical particles and 1 -10% isopropyl myristate.
5. A composition according to Claim 1 further comprising 1 -50% of an active ingredient suitable for topical application.
A lotion according to Claim 5 wherein the active is 1 -10% lanolin.
SUBSTITUTE SHEET 7. A composition according to Claim 5 formulated as a roll-on antiperspirant, wherein the active is 5-40% of an antiperspirant compound.
8. A composition of Claim 1 in the form of an anhydrous antiperspirant comprising by weight: a) 20 to 50% of cyclomethicone b) 1 to 10% polyoxypropylene-15-stearyl ether c) 5 to 20% stearyl alcohol d) 5 to 50% polyolefin microspherical particles e) 10 to 30% antiperspirant compound to a total of 100%.
9. A composition according to Claim 5 in the form of an anhydrous antiperspirant aerosol concentrate comprising: a) 15-50% cyclomethicone b) 1-20% isopropyl myristate c) 15-40% polyolefin microspherical particles d) 10-40% antiperspirant compound to a total of 100%.
10. A composition according to Claim 5 in the form of an anhydrous antiperspirant cream composition comprising: a) 30-50% cyclomethicone b) 1 -10% polyoxypropylene 14 butyl ether c) 15-40% polyolefin microspherical particles d) 10-30% antiperspirant compound to a total of 100%.
HEET 1 1. A composition according to Claim 5 in the form of a lotion, wherein the active ingredient in 1 -10% octadimethyl PABA and further comprising 1 -10% benzo-phenone-3.
12. A composition according to Claim 1 in the form of an anhydrous insect repellent, wherein the base is N,N, diethyl toluamide.
SUBSTITUTE SHEET 05261 _. g
AMENDED CLAIMS
[received by the International Bureau on 9 September 1993 (09.09.93); original claims 1,4,6,11,12 amended; new claims 13 and 14 added; other claims unchanged (2 pages)J
1. A liquid or semisolid anhydrous composition suitable for topi application, comprising an inactive carrier consisting essentially of; a) 10-80% by weight of an anhydrous pharmaceutically accepta topically applicable carrier which is liquid or semi-solid at room temperature; a b) 5-50% by weight of polyolefin microspherical particles having average diameter of less than 25 microns and having a density of greater th 0.915 g/ml, where the amount of microspherical particles constitutes at least 30% by wei of the said anhydrous pharmaceutically acceptable carrier.
2. A composition according to Claim 1 in the form of a lotion, wher the base is mineral oil or glycerin.
3. An composition according to Claim 1 in the form of an ointm wherein the base is petrolatum.
4. An composition according to Claim 1 in the form of an aer concentrate, comprising 10-80% decamethyl cyclopentasiloxane (pentamer) 50% polyolefin microspherical particles and 1-10% isopropyl myristate.
5. A composition according to Claim 1 further comprising 1 -50% o active ingredient suitable for topical application.
6. A composition according to Claim 5 wherein the active is 1 -1 lanolin. 11. A composition according to Claim 5 in the form of a lotion, wher the active ingredient is 1-10% octadimethyl PABA and further comprising 1-10 benzo-phenone-3.
12. A composition according to Claim 5 in the form of an anhydro insect repellent, wherein the active ingredient is N,N, diethyl toluamide.
13. A liquid or semisolid anhydrous composition suitable for topi application, comprising an inactive carrier consisting essentially of: a) 10-80% by weight of an anhydrous pharmaceutically accepta topically applicable carrier which is liquid or semi-solid at room temperature; a b) 15-50% by weight of polyolefin microspherical particles having average diameter of less than 25 microns and having a density of greater th 0.915 g/ml, where the amount of microspherical particles constitutes at least 30% by wei of the said anhydrous pharmaceutically acceptable carrier; and further
5 to 50% by weight of the total composition of an antiperspir compound.
14. A liquid or semisolid anhydrous composition suitable for topi application, consisting of: a) 10-80% by weight of an anhydrous pharmaceutically accepta topically applicable carrier which is liquid or semi-solid at room temperature; b) 5-50% by weight of polyolefin microspherical particles having average diameter of less than 25 microns and having a density of greater t 0.915 g/ml, where the amount of microspherical particles constitutes at le 30% by weight of the said anhydrous pharmaceutically acceptable carrier; a c) 5 to 50% by weight of an antiperspirant compound. STATEMENT UNDER ARTICLE 19
Claim 1 is clarified by further defining the "anhydrous composition", t "anhydrous base" and the "polyolefin microspherical particles" based on the origi disclosure at:
page 5, line 5 ("liquid or semi-solid" anhydrous composition and carrie
and page 5, line 15, ("density of greater than 0.915 g/ml").
Claim 1 , as amended, avoids the teachings of the cited references in that "polyolefinic microspherical particles" . (or "PMP") have a diameter of less than microns, a density of "greater than 0.915 g/ml," and are present at "at least 30% weight" of the amount of the anhydrous carrier. Accordingly, Applicants submit Cla 1 , as amended, does not lack inventive step over the references. The Amendme to Claims 4, 6, 1 1 and 12 are purely formal matters. Since these Claims, along w Claims 2, 3, 5, and 7-12 depend directly or indirectly from Claim 1 , it is submitt that all of Claims 2 through 12 also do not lack inventive step.
Applicants particularly note that the Examiner has not found Claims 7-10 lack inventive step over the references. Claims 7-10 accordingly are believed' npj lack inventive step.
It is further submitted that new Claims 13 and 14 - which do not go beyo the original disclosure at page 17, line 18 ("15%" PMP in original Claim 7 -- also av the cited references insofar as the composition they recite resembles that of Clai
7-10, i.e., includes an antiperspirant compound active ingredient. Additionally, n Claim 13 further avoids all the cited reference teachings by reciting PMP at a level "15-30%" by weight of the composition; while new Claim 14 further avoids t references by reciting an "anhydrous composition ... consisting of... 10-80% carrie 5-50%... polyolefinic microspherical particles... [and] 5-50% antiperspir compound."
PCT/US1992/007578 1991-04-12 1992-09-08 Anhydrous topical compositions which dry rapidly on contact WO1994005261A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US07/684,246 US5178881A (en) 1991-04-12 1991-04-12 Anhydrous topical compositions which dry rapidly on contact
US07/933,788 US5294447A (en) 1991-04-12 1992-08-24 Anhydrous topical compositions which dry rapidly on contact
CA002123118A CA2123118C (en) 1991-04-12 1992-09-08 Anhydrous topical compositions which dry rapidly on contact
PCT/US1992/007578 WO1994005261A1 (en) 1991-04-12 1992-09-08 Anhydrous topical compositions which dry rapidly on contact

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/684,246 US5178881A (en) 1991-04-12 1991-04-12 Anhydrous topical compositions which dry rapidly on contact
CA002123118A CA2123118C (en) 1991-04-12 1992-09-08 Anhydrous topical compositions which dry rapidly on contact
PCT/US1992/007578 WO1994005261A1 (en) 1991-04-12 1992-09-08 Anhydrous topical compositions which dry rapidly on contact

Publications (1)

Publication Number Publication Date
WO1994005261A1 true WO1994005261A1 (en) 1994-03-17

Family

ID=27169766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/007578 WO1994005261A1 (en) 1991-04-12 1992-09-08 Anhydrous topical compositions which dry rapidly on contact

Country Status (1)

Country Link
WO (1) WO1994005261A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000086500A (en) * 1998-09-18 2000-03-28 Toyo Aerosol Ind Co Ltd Aerosol type ointment composition
EP1337145A1 (en) * 2000-11-28 2003-08-27 Avon Products, Inc. Anhydrous insect repellent composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4009254A (en) * 1974-05-06 1977-02-22 Colgate-Palmolive Company Topical compositions
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
US4869897A (en) * 1987-10-22 1989-09-26 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4009254A (en) * 1974-05-06 1977-02-22 Colgate-Palmolive Company Topical compositions
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
US4869897A (en) * 1987-10-22 1989-09-26 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000086500A (en) * 1998-09-18 2000-03-28 Toyo Aerosol Ind Co Ltd Aerosol type ointment composition
EP1337145A1 (en) * 2000-11-28 2003-08-27 Avon Products, Inc. Anhydrous insect repellent composition
EP1337145A4 (en) * 2000-11-28 2009-05-27 Avon Prod Inc Anhydrous insect repellent composition

Similar Documents

Publication Publication Date Title
US5178881A (en) Anhydrous topical compositions which dry rapidly on contact
US5292530A (en) Stable anhydrous topically-active composition and suspending agent therefor
US4686099A (en) Aerosol waterproof sunscreen compositions
CA1278521C (en) Composition for personal care product comprising alkoxylated fatty alcohol and polysiloxane
US5444096A (en) Stable anhydrous topically-active composition and suspending agent therefor
US5294447A (en) Anhydrous topical compositions which dry rapidly on contact
EP1365742B1 (en) Anhydrous cosmetic or pharmaceutical two-phase compositions comprising a nonaqueous hydrophilic external phase, an internal oil phase and a gellant
US4710371A (en) Waterproof sunscreen compositions
CA2291232C (en) Water containing wax-based product
FR2801502A1 (en) COSMETIC DEODORANT ANHYDROUS COMPOSITION
JP2008504259A (en) Pharmaceutically elegant topical anhydrous aerosol foam
WO1994013353A1 (en) Separately packaged pads for topical drug delivery
KR20040042876A (en) Water-in-oil emulsion cosmetic composit ion
JPH0320210A (en) Locally adaptable and stable anhydrous composition
JPH0421642B2 (en)
KR101619428B1 (en) Oily cleansing cosmetic composition comprising oil absorbing material
JPS58183611A (en) Cosmetic of polyphase emulsification type
JPH10120525A (en) W/o-type emulsion cosmetic
WO1994005261A1 (en) Anhydrous topical compositions which dry rapidly on contact
US6124348A (en) Vitamin C skin formulations
CA2123118C (en) Anhydrous topical compositions which dry rapidly on contact
CA2265815C (en) Formulations for topical use
JP3273809B2 (en) Oil-in-water cream base
JP2654960B2 (en) Emulsion composition
JP3406438B2 (en) Water-in-oil emulsion cosmetics

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

WWE Wipo information: entry into national phase

Ref document number: 2123118

Country of ref document: CA

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase